# Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)

> **NCT00681980** · PHASE3 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 60 (actual)

## Conditions studied

- Paraparesis Spastic Tropical

## Interventions

- **DRUG:** Valproic acid
- **DRUG:** costicosteroids
- **DRUG:** valproid acid plus corticosteroids

## Key facts

- **NCT ID:** NCT00681980
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-09
- **Final completion:** 2015-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00681980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00681980, "Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00681980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*